SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-260361
Filing Date
2009-12-28
Accepted
2009-12-28 16:14:31
Documents
4
Period of Report
2009-12-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 27705
2 PRESS RELEASE dex991.htm EX-99.1 10066
3 GRAPHIC g60260g08w68.jpg GRAPHIC 4299
4 GRAPHIC g60260g09e09.jpg GRAPHIC 9594
  Complete submission text file 0001193125-09-260361.txt   58899
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 091262020
SIC: 2834 Pharmaceutical Preparations